Aarti Drugs Ltd. Fundamental & Technical Research, Share Price Today

NSE : AARTIDRUGS
NIFTY : Nifty Microcap 250

About Company

Aarti Drugs Limited was established in the year 1984 and forms part of Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science Private Limited. Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.

Market Cap. ₹ 4,401 Cr.

52 Week - High/Low ₹ 635/312

P/E Ratio 24.58

P/B Ratio 3.52

Enterprise Value ₹ 4,712 Cr.

ROE % 12.97

RSI Value 42.45

EMA 50 492.89

EMA 200 463.77

Market Cap. ₹ 4,401 Cr.

52 Week - High/Low ₹ 635/312

P/E Ratio 23.29

P/B Ratio 3.21

Enterprise Value ₹ 4,762 Cr.

ROE % 12.68

RSI Value 42.45

EMA 50 492.89

EMA 200 463.77

Add Parameters

Growth

View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us

Aarti Drugs Ltd.

₹482.2